Vimal Mehta, CEO and President at BioXcel Therapeutics, Inc. (BTAI), sold 98,396 shares at $18.22 ($1.8M) on 2023-03-20, disclosed to the SEC on 2023-03-22.
Open-market sale of $1.8M BTAI by CEO and President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.20 | 24,667 | $449K | 24.3% |
| 2 | $18.20 | 24,667 | $449K | 24.3% |
| 3 | $18.22 | 3,896 | $71K | 3.8% |
| 4 | $18.22 | 3,896 | $71K | 3.8% |
| 5 | $18.86 | 5,333 | $101K | 5.5% |
| 6 | $18.86 | 5,333 |
| $101K |
| 5.5% |
| 7 | $18.88 | 604 | $11K | 0.6% |
| 8 | $19.70 | 29,100 | $573K | 31.1% |
| 9 | $20.15 | 900 | $18K | 1.0% |
| Total | $18.74 avg | 98,396 | $1.8M | 100% |
| Filing → |
| BTAI | SELL | 2024-09-17 | $1K | — | Filing → |
| BTAI | SELL | 2024-06-18 | $3K | — | Filing → |
| BTAI | SELL | 2024-04-08 | $14K | — | Filing → |